2022
Online randomised factorial trial of electronic Screening and Brief Intervention for alcohol use in pregnancy: a study protocol
Ondersma SJ, Todd L, Jablonski S, Ahuja C, Gilstad-Hayden K, Goyert G, Loree A, Heffner J, Yonkers KA. Online randomised factorial trial of electronic Screening and Brief Intervention for alcohol use in pregnancy: a study protocol. BMJ Open 2022, 12: e062735. PMID: 35922101, PMCID: PMC9352990, DOI: 10.1136/bmjopen-2022-062735.Peer-Reviewed Original ResearchMeSH KeywordsAlcohol DrinkingCrisis InterventionElectronicsFemaleHumansMass ScreeningPregnancyPrenatal Exposure Delayed EffectsRandomized Controlled Trials as TopicConceptsPregnant womenBrief interventionAlcohol useFactorial trialHealth Institutional Review BoardAdverse perinatal outcomesFetal alcohol spectrum disordersUnhealthy alcohol useDose-response effectPrenatal alcohol exposureSpectrum of conditionsAlcohol spectrum disordersInstitutional review boardText messagingPeer-reviewed journalsPerinatal outcomesWeeks' gestationBirth outcomesPossible additional benefitsStudy protocolAlcohol exposureAlcohol abstinenceBooster sessionsEthical approvalPrimary analysis
2017
CDC Grand Rounds: Public Health Strategies to Prevent Neonatal Abstinence Syndrome
Ko JY, Wolicki S, Barfield WD, Patrick SW, Broussard CS, Yonkers KA, Naimon R, Iskander J. CDC Grand Rounds: Public Health Strategies to Prevent Neonatal Abstinence Syndrome. MMWR Morbidity And Mortality Weekly Report 2017, 66: 242-245. PMID: 28278146, PMCID: PMC5687191, DOI: 10.15585/mmwr.mm6609a2.Peer-Reviewed Original ResearchConceptsNeonatal abstinence syndromeMedication-assisted treatmentPrescription opioidsAbstinence syndromeCentral nervous system irritabilityDrug withdrawal syndromeOpioid use disorderHours of birthPublic health strategiesGastrointestinal dysfunctionOpioid exposurePain reliefWithdrawal syndromeUtero exposureClinical signsHealth strategiesUse disordersSyndromeOpioidsIllicit useExposurePregnancyDysfunctionInfantsIrritability
2015
Obstetric and Neonatal Outcomes After Antipsychotic Medication Exposure in Pregnancy
Coughlin CG, Blackwell KA, Bartley C, Hay M, Yonkers KA, Bloch MH. Obstetric and Neonatal Outcomes After Antipsychotic Medication Exposure in Pregnancy. Obstetrics And Gynecology 2015, 125: 1224-1235. PMID: 25932852, PMCID: PMC4418034, DOI: 10.1097/aog.0000000000000759.Peer-Reviewed Original ResearchConceptsAdverse birth outcomesGestational-age birthsAntipsychotic exposureNeonatal outcomesCohort studyBirth outcomesAntipsychotic medicationMajor malformationsBirth weightOdds ratioAntipsychotic medication exposureNeonatal birth weightPooled odds ratioPotential risk factorsUnexposed pregnanciesMedication exposurePreterm deliveryGestational ageAntipsychotic treatmentElective terminationPossible confoundersReproductive ageRisk factorsSpontaneous abortionSTUDY SELECTION
2004
Management of Bipolar Disorder During Pregnancy and the Postpartum Period
Yonkers KA, Wisner KL, Stowe Z, Leibenluft E, Cohen L, Miller L, Manber R, Viguera A, Suppes T, Altshuler L. Management of Bipolar Disorder During Pregnancy and the Postpartum Period. American Journal Of Psychiatry 2004, 161: 608-620. PMID: 15056503, DOI: 10.1176/appi.ajp.161.4.608.Peer-Reviewed Original ResearchConceptsMood stabilizersBipolar disorderPostpartum periodFuture reproductive plansBipolar disorder patientsIssue of pregnancyPeripartum womenCohort studyPostpartum womenPregnant womenSodium valproateDisturbed sleepReproductive yearsHuman teratogenPsychotic componentsGeneral populationDisorder patientsPregnancyConsensus documentAmerican Psychiatric AssociationReproductive plansDisordersEarly adulthoodExpert panelWomen